Caris Life Sciences, Inc. (CAI) Investor Relations Documents

Caris Life Sciences, Inc. (CAI) investor relations documents from the company's IR site: 2 presentations, 24 press releases; latest deck 2026-02-26. Read in-app with summaries. First-party data.

Caris Fourth Quarter and Full Year 2025 Financial Results Conference Presentation: Caris Life Sciences Q4 2025 earnings report shows $292.9M in quarterly revenue, driven by a 125% GAAP revenue increase and strong clinical volume growth.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-05	Press release	Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-07-16	Press release	Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-01	Press release	Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blo
2026-06-16	Press release	Caris Life Sciences Announces Dual Listing on NYSE Texas
2026-06-08	Press release	Caris Life Sciences Announces Share Repurchase Program
2026-05-26	Press release	Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensiv
2026-05-15	Press release	Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehens
2026-05-11	Press release	Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Over
2026-05-08	Press release	Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Auth
	Press release	Caris Life Sciences Reports First Quarter 2026 Financial Results
2026-04-29	Press release	Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
2026-04-24	Press release	Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Glob
2026-04-17	Press release	Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
2026-04-08	Press release	Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition
2026-03-31	Press release	Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Dete
2026-03-26	Press release	Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung
2026-02-26	Earnings deck	Caris Fourth Quarter and Full Year 2025 Financial Results Conference Presentation
2026-02-26	Press release	Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
2026-02-23	Press release	Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
2026-02-09	Press release	Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
2026-01-28	Press release	Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab D
2026-01-12	Presentation	44th Annual J.P. Morgan Healthcare Conference Presentation
2026-01-12	Press release	Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect
2026-01-12	Press release	Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
2026-01-05	Press release	Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
	Press release	Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing

CAI overview · CAI earnings · CAI financials · CAI KPIs · CAI documents · CAI ownership · CAI peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.